vTv Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio89.3826.7616.6315.27
P/B Ratio6.36-1.269.254.3825.82
Price/Tangible Book7.45
Enterprise Value Ratios
EV/Revenue51.4931.6923.2022.52
Profitability & Returns
Return on Equity (ROE)-2.38%-1.86%
Return on Assets (ROA)-0.61%-0.72%-0.48%-0.62%-0.62%
Return on Capital Employed (ROCE)-0.73%-63.91%-0.88%-1.18%-1.41%
Leverage & Solvency Ratios
Debt/Equity0.01-0.030.120.060.24
Liquidity Ratios
Current Ratio7.331.003.521.841.13
Quick Ratio7.100.911.601.610.98
Efficiency Ratios
Asset Turnover0.040.070.200.53
Yield & Distribution Ratios
Earnings Yield-0.20%-0.86%-0.35%-0.20%-0.09%
FCF Yield-0.28%-0.81%-0.30%-0.29%-0.18%
Buyback Yield-1.77%-0.09%-0.23%-0.33%-0.56%